Promising pipeline ensures mid- and long-term innovation
Balanced mix of new substance developments and life cycle management opportunities
In this context, Bayer Schering Pharma focuses on its core competencies and its many years of experience. We thus hold a leading position in many therapeutic fields: for instance in the treatment of hemophilia and multiple sclerosis, in contrast media and oral contraception. We are also striving for such a leading position in oncology. With new approaches in cancer therapy, cardiovascular diseases, gynaecological therapies and molecular imaging Bayer Schering Pharma seeks to become an innovation leader in these fields. In addition, Bayer Schering Pharma is further developing currently marketed products in order to improve their application and/or extend the range of indications.
